Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecloderm vs Lotricomb vs vehicle in inflamed cutaneous candidiasis
2024-514364-54-00Phase 3Authorised
- Sponsor
- Dermapharm
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of meclocycline in cutaneous candidiasis (3 arms), sponsored by Dermapharm. Planned start Aug 2024; status: authorised.
02
Drugs
meclocycline
03
Conditions
cutaneous candidiasis
Beyond the preview
Go deeper on 2024-514364-54-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514364-54-00.